Dr. Connie Batlevi, MD, PhD, MS
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Lymphoma
Studies Follicular Lymphoma
4 reported clinical trials
6 drugs studied
Area of expertise
1Lymphoma
EZH2 positive
CNG positive
CNG negative
2Follicular Lymphoma
EZH2 positive
CNG positive
CNG negative
Affiliated Hospitals
Clinical Trials Connie Batlevi, MD, PhD, MS is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
N-Acetylcysteine
for Lymphoma
The purpose of this study is to test the safety of N-AC when given in combination with Yescarta to people with lymphoma. This study will test different doses of N-AC to find the highest dose that causes few or mild side effects in participants.
Recruiting1 award Phase 1
More about Connie Batlevi, MD, PhD, MS
Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Connie Batlevi, MD, PhD, MS has experience with
- N-Acetylcysteine
- CfDNA
- Abexinostat
- Lenalidomide
- Rituximab
- Tazemetostat
Breakdown of trials Connie Batlevi, MD, PhD, MS has run
Lymphoma
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Connie Batlevi, MD, PhD, MS specialize in?
Connie Batlevi, MD, PhD, MS focuses on Lymphoma and Follicular Lymphoma. In particular, much of their work with Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is Connie Batlevi, MD, PhD, MS currently recruiting for clinical trials?
Yes, Connie Batlevi, MD, PhD, MS is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Connie Batlevi, MD, PhD, MS has studied deeply?
Yes, Connie Batlevi, MD, PhD, MS has studied treatments such as N-Acetylcysteine, cfDNA, Abexinostat.
What is the best way to schedule an appointment with Connie Batlevi, MD, PhD, MS?
Apply for one of the trials that Connie Batlevi, MD, PhD, MS is conducting.
What is the office address of Connie Batlevi, MD, PhD, MS?
The office of Connie Batlevi, MD, PhD, MS is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.